Sunshine Act Meeting: Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ATSDR), 34674-34675 [2017-15782]
Download as PDF
<![CDATA[
34674
Federal Register / Vol. 82, No. 142 / Wednesday, July 26, 2017 / Notices
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, Ohio 45226–1998.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
Centers for Disease Control and
Prevention
[CDC–2016–0090; Docket Number NIOSH
288–A]
[FR Doc. 2017–15727 Filed 7–25–17; 8:45 am]
A Performance Test Protocol for
Closed System Transfer Devices Used
During Pharmacy Compounding and
Administration of Hazardous Drugs;
Extension of Comment Period
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
Sunshine Act Meeting: Board of
Scientific Counselors, National Center
for Environmental Health/Agency for
Toxic Substances and Disease
Registry (BSC, NCEH/ATSDR)
AGENCY:
Notice and extension of
comment period.
ACTION:
On September 15, 2016 the
National Institute for Occupational
Safety and Health (NIOSH) of the
Centers for Disease Control and
Prevention (CDC), published a notice in
the Federal Register [81 FR 63482]
announcing a public meeting and
request for public comment on a draft
testing protocol.
Written comments were to be received
by December 7, 2016. NIOSH initially
extended the public comment period to
June 7, 2017 [81 FR 88687]. NIOSH
extended the comment period again to
August 30, 2017 [82 FR 25290]. NIOSH
is extending the public comment period
to close on February 28, 2018. The
longer timeframe will allow companies
to test the protocol with the proposed
challenge agents and permit full
participation in the protocol design
process.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Deborah V. Hirst, NIOSH, Alice
Hamilton Laboratories, 1090 Tusculum
Avenue, MS R–5, Cincinnati, Ohio
45226, telephone (513) 841–4141 (not a
toll free number), Email: DHirst@
cdc.gov.
You may submit comments,
identified by CDC–2016–0090 and
Docket Number NIOSH 288–A, by either
of the following two methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
mstockstill on DSK30JT082PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
17:49 Jul 25, 2017
Jkt 241001
BILLING CODE 4163–19–P
Centers for Disease Control and
Prevention
TIMES AND DATES:
8:30 a.m.–4:30 p.m., EDT, September 13,
2017
8:30 a.m.–11:30 a.m., EDT, September
14, 2017
PLACE: CDC, 4770 Buford Highway,
Building 102, Conference Room 2202,
Atlanta, Georgia 30341.
STATUS: In accordance with section
10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92–463), the
Centers for Disease Control and
Prevention announces the meeting of
the BSC, NCEH/ATSDR. This meeting is
open to the public. The meeting room
accommodates approximately 60
people. The public is also welcome to
listen to the meeting by joining the
teleconference at the USA toll-free, dialin number, 1–888–790–2009 Passcode:
7865774. The deadline for notification
of attendance is August 30, 2017. The
public comment period is scheduled on
Wednesday, September 13, 2017 from
2:00 p.m. until 2:15 p.m.; from 2:40 p.m.
until 2:55 p.m.; and from 3:25 p.m. until
3:40 p.m., and on Thursday, September
14, 2017 from 10:10 a.m. until 10:25
a.m. EDT (15 minutes). Individuals
wishing to make a comment during
Public Comment period, please email
your name, organization, and phone
number by Monday, September 4, 2017
to Dr. William Cibulas at wic1@cdc.gov.
MATTERS TO BE CONSIDERED: The
Secretary, Department of Health and
Human Services (HHS) and by
delegation, the Director, CDC and
Administrator, NCEH/ATSDR, are
authorized under Section 301 (42 U.S.C.
241) and Section 311 (42 U.S.C. 243) of
the Public Health Service Act, as
amended, to: (1) Conduct, encourage,
cooperate with, and assist other
appropriate public authorities, scientific
institutions, and scientists in the
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes, diagnosis,
treatment, control, and prevention of
physical and mental diseases and other
impairments; (2) assist states and their
political subdivisions in the prevention
of infectious diseases and other
preventable conditions and in the
promotion of health and wellbeing; and
(3) train state and local personnel in
health work. The BSC, NCEH/ATSDR
provides advice and guidance to the
Secretary, HHS; the Director, CDC and
Administrator, ATSDR; and the
Director, NCEH/ATSDR, regarding
program goals, objectives, strategies, and
priorities in fulfillment of the agency’s
mission to protect and promote people’s
health. The Board provides advice and
guidance that will assist NCEH/ATSDR
in ensuring scientific quality,
timeliness, utility, and dissemination of
results. The Board also provides
guidance to help NCEH/ATSDR work
more efficiently and effectively with its
various constituents and to fulfill its
mission in protecting America’s health.
The agenda items for the BSC Meeting
will include NCEH/ATSDR Director
Updates; Noise-Induced Hearing Loss;
NCEH/ATSDR Program Responses to
BSC Guidance and Action Items; Lead
Poisoning Prevention Program Updates;
Flint Registry; Revision of blood lead
level reference value (status); Discussion
of Legislative Requirements of new Lead
Exposure Poisoning Federal Advisory
Committee; Amyotrophic Lateral
Sclerosis (ALS) Program Update;
Environmental Health Tracking Program
update; updates from the National
Institute of Environmental Health
Sciences, the National Institute for
Occupational Safety and Health, the US
Department of Energy and the US
Environmental Protection Agency.
Agenda items are subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
Shirley Little, NCEH/ATSDR, CDC, 4770
Buford Highway, Mail Stop F–45,
Atlanta, Georgia 30341; Telephone 770/
488–0577, Email: snl7@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
E:\FR\FM\26JYN1.SGM
26JYN1
Federal Register / Vol. 82, No. 142 / Wednesday, July 26, 2017 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. 2017–15782 Filed 7–24–17; 11:15 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK30JT082PROD with NOTICES
Sunshine Act Meeting: Board of
Scientific Counselors, National Center
for Health Statistics (NCHS)
TIMES AND DATES:
11:00 a.m.–5:30 p.m., EDT, September 6,
2017
8:30 a.m.–1:00 p.m., EDT, September 7,
2017
PLACE: NCHS Headquarters, 3311
Toledo Road, Hyattsville, Maryland
20782.
STATUS: In accordance with section
10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92–463), the
Centers for Disease Control and
Prevention (CDC), National Center for
Health Statistics (NCHS) announces the
following meeting of the
aforementioned committee. This
meeting is open to the public; however,
visitors must be processed in
accordance with established federal
policies and procedures. For foreign
nationals or non-U.S. citizens, preapproval is required (please contact
Gwen Mustaf, 301–458–4500, glm4@
cdc.gov, or Virginia Cain, vcain@cdc.gov
at least 10 days in advance for
requirements). All visitors are required
to present a valid form of picture
identification issued by a state, federal
or international government. As
required by the Federal Property
Management Regulations, Title 41, Code
of Federal Regulation, Subpart 101–
20.301, all persons entering in or on
Federal controlled property and their
packages, briefcases, and other
containers in their immediate
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances. The meeting room
accommodates approximately 78
people.
MATTERS TO BE CONSIDERED: This
committee is charged with providing
advice and making recommendations to
the Secretary, Department of Health and
VerDate Sep<11>2014
19:21 Jul 25, 2017
Jkt 241001
Human Services; the Director, CDC; and
the Director, NCHS, regarding the
scientific and technical program goals
and objectives, strategies, and priorities
of NCHS. The agenda includes welcome
remarks by NCHS leadership; update
from the Division of Health Care
Statistics; update on National
Committee on Vital and Health
Statistics (NCVHS) activities; update on
improving data collection.
Requests to make oral presentations
should be submitted in writing to the
contact person listed below. All requests
must contain the name, address,
telephone number, and organizational
affiliation of the presenter. Written
comments should not exceed five
single-spaced typed pages in length and
must be received by August 22, 2017.
Agenda items are subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
Virginia S. Cain, Ph.D., Director of
Extramural Research, NCHS/CDC, 3311
Toledo Road, Room 2627, Hyattsville,
Maryland 20782, telephone (301) 458–
4500, email vcain@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2017–15783 Filed 7–24–17; 11:15 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–1984–14, CMS–
10326, CMS–2088–17, CMS–10452, CMS–
10320 and CMS–10418]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
SUMMARY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
34675
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected; and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
Comments on the collection(s) of
information must be received by the
OMB desk officer by August 25, 2017.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR, Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
Web site address at https://
www.cms.gov/Regulations-andGuidance/Legislation/Paperwork
ReductionActof1995/PRA-Listing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
DATES:
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 82, Number 142 (Wednesday, July 26, 2017)]
[Notices]
[Pages 34674-34675]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15782]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Sunshine Act Meeting: Board of Scientific Counselors, National
Center for Environmental Health/Agency for Toxic Substances and Disease
Registry (BSC, NCEH/ATSDR)
TIMES AND DATES:
8:30 a.m.-4:30 p.m., EDT, September 13, 2017
8:30 a.m.-11:30 a.m., EDT, September 14, 2017
PLACE: CDC, 4770 Buford Highway, Building 102, Conference Room 2202,
Atlanta, Georgia 30341.
STATUS: In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention announces the meeting of the BSC, NCEH/ATSDR. This meeting
is open to the public. The meeting room accommodates approximately 60
people. The public is also welcome to listen to the meeting by joining
the teleconference at the USA toll-free, dial-in number, 1-888-790-2009
Passcode: 7865774. The deadline for notification of attendance is
August 30, 2017. The public comment period is scheduled on Wednesday,
September 13, 2017 from 2:00 p.m. until 2:15 p.m.; from 2:40 p.m. until
2:55 p.m.; and from 3:25 p.m. until 3:40 p.m., and on Thursday,
September 14, 2017 from 10:10 a.m. until 10:25 a.m. EDT (15 minutes).
Individuals wishing to make a comment during Public Comment period,
please email your name, organization, and phone number by Monday,
September 4, 2017 to Dr. William Cibulas at wic1@cdc.gov.
Matters To Be Considered: The Secretary, Department of Health and Human
Services (HHS) and by delegation, the Director, CDC and Administrator,
NCEH/ATSDR, are authorized under Section 301 (42 U.S.C. 241) and
Section 311 (42 U.S.C. 243) of the Public Health Service Act, as
amended, to: (1) Conduct, encourage, cooperate with, and assist other
appropriate public authorities, scientific institutions, and scientists
in the conduct of research, investigations, experiments,
demonstrations, and studies relating to the causes, diagnosis,
treatment, control, and prevention of physical and mental diseases and
other impairments; (2) assist states and their political subdivisions
in the prevention of infectious diseases and other preventable
conditions and in the promotion of health and wellbeing; and (3) train
state and local personnel in health work. The BSC, NCEH/ATSDR provides
advice and guidance to the Secretary, HHS; the Director, CDC and
Administrator, ATSDR; and the Director, NCEH/ATSDR, regarding program
goals, objectives, strategies, and priorities in fulfillment of the
agency's mission to protect and promote people's health. The Board
provides advice and guidance that will assist NCEH/ATSDR in ensuring
scientific quality, timeliness, utility, and dissemination of results.
The Board also provides guidance to help NCEH/ATSDR work more
efficiently and effectively with its various constituents and to
fulfill its mission in protecting America's health. The agenda items
for the BSC Meeting will include NCEH/ATSDR Director Updates; Noise-
Induced Hearing Loss; NCEH/ATSDR Program Responses to BSC Guidance and
Action Items; Lead Poisoning Prevention Program Updates; Flint
Registry; Revision of blood lead level reference value (status);
Discussion of Legislative Requirements of new Lead Exposure Poisoning
Federal Advisory Committee; Amyotrophic Lateral Sclerosis (ALS) Program
Update; Environmental Health Tracking Program update; updates from the
National Institute of Environmental Health Sciences, the National
Institute for Occupational Safety and Health, the US Department of
Energy and the US Environmental Protection Agency.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Shirley Little, NCEH/ATSDR, CDC,
4770 Buford Highway, Mail Stop F-45, Atlanta, Georgia 30341; Telephone
770/488-0577, Email: snl7@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and
[[Page 34675]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention.
[FR Doc. 2017-15782 Filed 7-24-17; 11:15 am]
BILLING CODE 4163-18-P
